1. Home
  2. PRQR vs HYLN Comparison

PRQR vs HYLN Comparison

Compare PRQR & HYLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • HYLN
  • Stock Information
  • Founded
  • PRQR 2012
  • HYLN 2018
  • Country
  • PRQR Netherlands
  • HYLN United States
  • Employees
  • PRQR N/A
  • HYLN N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • HYLN Construction/Ag Equipment/Trucks
  • Sector
  • PRQR Health Care
  • HYLN Consumer Discretionary
  • Exchange
  • PRQR Nasdaq
  • HYLN Nasdaq
  • Market Cap
  • PRQR 309.5M
  • HYLN 279.7M
  • IPO Year
  • PRQR 2014
  • HYLN N/A
  • Fundamental
  • Price
  • PRQR $1.27
  • HYLN $1.32
  • Analyst Decision
  • PRQR Strong Buy
  • HYLN Hold
  • Analyst Count
  • PRQR 6
  • HYLN 1
  • Target Price
  • PRQR $8.50
  • HYLN $2.00
  • AVG Volume (30 Days)
  • PRQR 694.9K
  • HYLN 966.0K
  • Earning Date
  • PRQR 03-13-2025
  • HYLN 04-29-2025
  • Dividend Yield
  • PRQR N/A
  • HYLN N/A
  • EPS Growth
  • PRQR N/A
  • HYLN N/A
  • EPS
  • PRQR N/A
  • HYLN N/A
  • Revenue
  • PRQR $20,235,014.00
  • HYLN $1,509,000.00
  • Revenue This Year
  • PRQR $39.44
  • HYLN $1,360.04
  • Revenue Next Year
  • PRQR N/A
  • HYLN $64.35
  • P/E Ratio
  • PRQR N/A
  • HYLN N/A
  • Revenue Growth
  • PRQR 196.41
  • HYLN 124.55
  • 52 Week Low
  • PRQR $1.25
  • HYLN $1.21
  • 52 Week High
  • PRQR $4.62
  • HYLN $4.10
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 22.66
  • HYLN 31.87
  • Support Level
  • PRQR $1.25
  • HYLN $1.34
  • Resistance Level
  • PRQR $1.39
  • HYLN $1.45
  • Average True Range (ATR)
  • PRQR 0.09
  • HYLN 0.09
  • MACD
  • PRQR -0.01
  • HYLN -0.00
  • Stochastic Oscillator
  • PRQR 3.92
  • HYLN 1.43

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceuticals company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp provides solutions that enable clean, flexible, and affordable electricity production. The Company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. It is initially targeting the commercial and waste management industries with a locally deployable generator that can offer prime power as well as energy arbitrage opportunities. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies.

Share on Social Networks: